The goal is to provide health professionals a faster access to updated oncology research data and promoting better and broader cancer practices. The support tool will help physicians to establish personalized oncological diagnoses and treatment recommendations based on observational evidence.
The initiative will combine the IBM's Watson supercomputer's technology and his hability to transform the clinical knowledge of the MSKCC into natural language, including molecular and genomic data and a vast repository of cancer patients, in order to create a support system decision based on evidence.
The goal is to provide oncologists, anywhere in the world, the ability to obtain detailed options for diagnosis and treatment based on current research, that will help them decide the best care for each patient.
“The goal is to help better identify and customize cancer treatments, regardless of the location of the patient. We also hope that this collaboration will bring new research opportunities”, said Craig B. Thompson, CEO of Memorial Sloan-Kettering Cancer Center.
The goal is to deliver the first solutions to a select group of oncologists at the end of 2012, with wider distribution planned for late 2013.
Deixe um comentário
Tem de iniciar a sessão para publicar um comentário.